tirzepatide for perimenopause One of the biggest misconceptions I see in women navigating is that GLP-1 medications are simply “weight loss drugs.” That couldn't be further from the truth, and it's time more women New research presented at ENDO

If one is needed, we recommend an in-person visit with your PCP to help you discuss your options

A microdose tirzepatide schedule can reduce side effects significantly while still providing appetite suppression

The satiety-promoting effects of pramlintide extend beyond diabetic populations to obese non-diabetic individuals, reducing ad libitum food intake and meal duration through area postrema and hypothalamic signaling

F1000Research 7 , 356 (2018)

Yes LifeRx publicly announced CareCredit acceptance in September 2025

Research chemical status SS-31 is available from research chemical suppliers for laboratory research purposes